Audrey Jordana

Audrey Jordana is an experienced professional in the biotechnology and pharmaceutical sectors, currently serving as the CMC program lead at Alentis Therapeutics since September 2023. Prior to this role, Audrey held multiple positions at Sobi – Swedish Orphan Biovitrum AB, including Global Manufacturing and Supply Project Manager and External Manufacturing Manager, where responsibilities included leading complex Tech'Ops programs and managing relationships with CMOs. Previous experience at AC Immune involved leading manufacturing projects for monoclonal antibodies and coordinating supply for clinical trials. Earlier roles included bioprocessing upstream engineer at NovImmune, R&D process development engineer at PX Therapeutics, and R&D engineer at Pierre Fabre. Audrey holds an engineering degree in biotechnology from ENSTBB and a Clinical Research Associate qualification from Clinact.